Traumeel S: Bioregulatory Approach to Analgesic Therapy of Spine and Joints Diseases

Abstract

The problem of pain occupies a special place in the theoretical and practical medicine. Pain — the main complaint, forcing seek advice, assistance, one of the most frequent causes of health encounter. Every tenth inhabitant of our planet is experiencing pain associated with dysfunction of the joints and spine, the development of osteoarthritis and degenerative disc disease. The article provides a brief overview of the clinical studies that demonstrate the timeliness of bioregulatory approach use. Traumeel S (manufactured by Biologische Heilmittel Heel GmbH, Germany) is an antiinflammatory drug, which is widely used for the treatment of pain syndrome in inflammatory and degenerative dystrophic diseases, as well as in traumas.

Keywords

• pain syndrome
• bioregulatory approach
• combined bioregulatory drugs
• Traumeel S